News | January 06, 2026
PHARMEXCIL holds high-level talks with government to boost India’s pharma exports
India’s pharmaceutical sector stands at a pivotal inflection point
India’s pharmaceutical sector stands at a pivotal inflection point
Pembrolizumab has shown meaningful benefit only when combined with chemotherapy
India’s traditional medicine systems have also earned formal recognition in key bilateral trade agreements
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The trials did not show a statistically significant reduction in annualized clinical fracture rates compared to placebo or bisphosphonates
The company announced that it has been granted patent covering “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives.”
Transcenta will grant EirGenix a non-exclusive license to its Highly Intensified Continuous Bioprocessing (HiCB) platform
Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
Subscribe To Our Newsletter & Stay Updated
